Trials / Completed
CompletedNCT04337268
Acute Effects of GLP-1 on Renal Hemodynamics
Acute Effects of GLP-1 on Renal Hemodynamics: Simultaneous Perfusion and Oxygenation Measurements in Cortex and Medulla Using Magnetic Resonance Imaging
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- Male
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study investigates the hypothesis, that GLP-1's suppression of ANG II and natriuretic action increase medullary perfusion and decrease oxygen consumption, leading to higher tissue oxygenation.
Detailed description
Human studies have recently demonstrated a significant natriuretic effect of GLP-1 when the extracellular fluid volume (ECFV) is expanded by intravenous sodium-loading; in these studies, there was a suppression of ANG II with no change in net renal hemodynamics, pointing to a tubular mechanism for reduced NaCl reabsorption secondary to the ANG II suppression. In the current randomized and controlled study, investigators aim to test the hypothesis that GLP-1's suppression of ANG II and natriuretic action increase medullary perfusion and decrease oxygen consumption, leading to higher tissue oxygenation. Thus, contributing to the renoprotective action of GLP-1. Under fixed sodium intake for 4 days before each study day, 10 healthy male participants will be investigated during a 1-hour infusion of GLP-1 (1.5 pmol/kg/min) or vehicle together with an intravenous infusion of 0.9% NaCl. Interleaved measurements of RAF, oxygenation (T2\*) and perfusion by arterial spin labeling in the renal cortex and medulla at fixed time points will be conducted, using Magnetic Resonance Imaging (MRI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucagon-Like Peptide 1 | Intravenous infusion (1.5 pmol/kg/min) for 60 min. |
| DRUG | saline 0.9% | Intravenous infusion for 60 min. |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2020-04-07
- Last updated
- 2020-04-07
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04337268. Inclusion in this directory is not an endorsement.